Search

Your search keyword '"Wood, Michael"' showing total 235 results

Search Constraints

Start Over You searched for: Author "Wood, Michael" Remove constraint Author: "Wood, Michael" Publisher elsevier bv Remove constraint Publisher: elsevier bv
235 results on '"Wood, Michael"'

Search Results

8. Corrigendum to “Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression” [American Journal of Transplantation (2022) 2571–2585]

13. Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression

17. Best practices for predictions of radionuclide activity concentrations and total absorbed dose rates to freshwater organisms exposed to uranium mining/milling

24. Integration of ecosystem science into radioecology: A consensus perspective

28. SAR inspired by aldehyde oxidase (AO) metabolism: Discovery of novel, CNS penetrant tricyclic M4 PAMs

29. VU6005806/AZN-00016130, an advanced M4 positive allosteric modulator (PAM) profiled as a potential preclinical development candidate

31. Measuring the radiation exposure of Norwegian reindeer under field conditions

32. Corrigendum to “Challenges in the development of an M4 PAM preclinical candidate: The discovery, SAR, and biological characterization of a series of azetidine-derived tertiary amides” [Bioorg. Med. Chem. Lett. 27(23) (2017) 5179–5184]

33. Challenges in the development of an M 4 PAM preclinical candidate: The discovery, SAR, and biological characterization of a series of azetidine-derived tertiary amides

35. P129. Improving Breast Cancer Patient Experience Through Innovative Design Thinking

38. Novel M4 positive allosteric modulators derived from questioning the role and impact of a presumed intramolecular hydrogen-bonding motif in β-amino carboxamide-harboring ligands

46. Challenges in the development of an M 4 PAM preclinical candidate: The discovery, SAR, and in vivo characterization of a series of 3-aminoazetidine-derived amides

47. Optimization of M 4 positive allosteric modulators (PAMs): The discovery of VU0476406, a non-human primate in vivo tool compound for translational pharmacology

48. Challenges in the development of an M 4 PAM in vivo tool compound: The discovery of VU0467154 and unexpected DMPK profiles of close analogs

49. Bicyclo((aryl)methyl)benzamides as inhibitors of GlyT1

Catalog

Books, media, physical & digital resources